Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP980041.RA37J1WyfPrSQH1gI5ivTVW4J0vHD2qcCKqH6Go4zCe6g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP980041.RA37J1WyfPrSQH1gI5ivTVW4J0vHD2qcCKqH6Go4zCe6g130_assertion type Assertion NP980041.RA37J1WyfPrSQH1gI5ivTVW4J0vHD2qcCKqH6Go4zCe6g130_head.
- NP980041.RA37J1WyfPrSQH1gI5ivTVW4J0vHD2qcCKqH6Go4zCe6g130_assertion description "[KD of SLC25A43 also reduced the inhibitory effect of trastuzumab on cell proliferation in the HER2-positive cancer cell line BT-474 (P<0.05), and the drug-induced G0/G1�block (P<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP980041.RA37J1WyfPrSQH1gI5ivTVW4J0vHD2qcCKqH6Go4zCe6g130_provenance.
- NP980041.RA37J1WyfPrSQH1gI5ivTVW4J0vHD2qcCKqH6Go4zCe6g130_assertion evidence source_evidence_literature NP980041.RA37J1WyfPrSQH1gI5ivTVW4J0vHD2qcCKqH6Go4zCe6g130_provenance.
- NP980041.RA37J1WyfPrSQH1gI5ivTVW4J0vHD2qcCKqH6Go4zCe6g130_assertion SIO_000772 23354756 NP980041.RA37J1WyfPrSQH1gI5ivTVW4J0vHD2qcCKqH6Go4zCe6g130_provenance.
- NP980041.RA37J1WyfPrSQH1gI5ivTVW4J0vHD2qcCKqH6Go4zCe6g130_assertion wasDerivedFrom befree-20150227 NP980041.RA37J1WyfPrSQH1gI5ivTVW4J0vHD2qcCKqH6Go4zCe6g130_provenance.
- NP980041.RA37J1WyfPrSQH1gI5ivTVW4J0vHD2qcCKqH6Go4zCe6g130_assertion wasGeneratedBy ECO_0000203 NP980041.RA37J1WyfPrSQH1gI5ivTVW4J0vHD2qcCKqH6Go4zCe6g130_provenance.